[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fcZXloOIVljoteozgskJUPNBd3V2dVprmxie-8wuCoMI":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":8,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":30,"phaseBuckets":36,"rows":43},"Universidade Federal de Goias",[4],42,false,2,3,3548,29,[13,16,18,20,22,24,26,28],{"name":14,"count":15},"Edentulous Mouth",4,{"name":17,"count":9},"Mouth, Edentulous",{"name":19,"count":9},"Aging",{"name":21,"count":9},"Complete Edentulism",{"name":23,"count":9},"Child Behavior",{"name":25,"count":8},"Dental Anxiety",{"name":27,"count":8},"Exercise",{"name":29,"count":8},"Breast Cancer",[31],{"nctId":32,"briefTitle":33,"date":34,"intervention":35},"NCT04119180","Sedation Versus Protective Stabilization for Pediatric Dental Treatment","2025-02-28","Ketamine 50 MG\u002FML",[37,38,39,40,41,42],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[44,70,88,128,155,173,201,219,237,255,285,303,321,349,367,385,413,431,458,476,502,520,548,566,584,610,636],{"intervention":35,"totalTrials":45,"cells":46},1,{"EARLY_PHASE1":47,"PHASE1":50,"PHASE2":52,"PHASE3":54,"PHASE4":56,"NA":68},{"trials":48,"activeCount":49},[],0,{"trials":51,"activeCount":49},[],{"trials":53,"activeCount":49},[],{"trials":55,"activeCount":49},[],{"trials":57,"activeCount":45,"soonestReadout":34},[58],{"nctId":32,"briefTitle":33,"status":59,"phases":60,"primaryCompletion":34,"completion":61,"start":62,"enrollment":63,"conditions":64,"interventions":66},"RECRUITING",[41],"2026-02-28","2020-01-30",152,[23,65],"Dental Caries in Children",[35,67],"Midazolam Hcl 2Mg\u002FMl Syrup",{"trials":69,"activeCount":49},[],{"intervention":67,"totalTrials":45,"cells":71},{"EARLY_PHASE1":72,"PHASE1":74,"PHASE2":76,"PHASE3":78,"PHASE4":80,"NA":86},{"trials":73,"activeCount":49},[],{"trials":75,"activeCount":49},[],{"trials":77,"activeCount":49},[],{"trials":79,"activeCount":49},[],{"trials":81,"activeCount":45,"soonestReadout":34},[82],{"nctId":32,"briefTitle":33,"status":59,"phases":83,"primaryCompletion":34,"completion":61,"start":62,"enrollment":63,"conditions":84,"interventions":85},[41],[23,65],[35,67],{"trials":87,"activeCount":49},[],{"intervention":89,"totalTrials":8,"cells":90},"Midazolam",{"EARLY_PHASE1":91,"PHASE1":93,"PHASE2":95,"PHASE3":97,"PHASE4":99,"NA":126},{"trials":92,"activeCount":49},[],{"trials":94,"activeCount":49},[],{"trials":96,"activeCount":49},[],{"trials":98,"activeCount":49},[],{"trials":100,"activeCount":49},[101,115],{"nctId":102,"briefTitle":103,"status":104,"phases":105,"primaryCompletion":106,"completion":107,"start":108,"enrollment":109,"conditions":110,"interventions":113},"NCT00902395","Efficacy of Moderate Sedation for Dental Treatment of Young Children","COMPLETED",[41],"2010-12","2012-05","2008-06",41,[111,23,112],"Dental Caries","Conscious Sedation Failure During Procedure",[89,114],"Midazolam, ketamine",{"nctId":116,"briefTitle":117,"status":104,"phases":118,"primaryCompletion":119,"completion":120,"start":121,"enrollment":122,"conditions":123,"interventions":125},"NCT01795222","Midazolam Efficacy for Sedating Preschoolers Undergoing Dental Treatment",[41],"2012-12","2013-02","2012-03",18,[124],"Early Childhood Caries",[89],{"trials":127,"activeCount":49},[],{"intervention":129,"totalTrials":45,"cells":130},"Dexmedetomidine Hydrochloride",{"EARLY_PHASE1":131,"PHASE1":133,"PHASE2":135,"PHASE3":137,"PHASE4":139,"NA":153},{"trials":132,"activeCount":49},[],{"trials":134,"activeCount":49},[],{"trials":136,"activeCount":49},[],{"trials":138,"activeCount":49},[],{"trials":140,"activeCount":49},[141],{"nctId":142,"briefTitle":143,"status":104,"phases":144,"primaryCompletion":145,"completion":146,"start":147,"enrollment":148,"conditions":149,"interventions":151},"NCT03290625","Intranasal Sedation With Dexmedetomidine and Ketamine in Pediatric Dentistry (NASO II)",[41],"2019-09-12","2020-03-05","2017-11-09",12,[150,25],"Caries of Infancy",[129,152],"Ketamine Hydrochloride",{"trials":154,"activeCount":49},[],{"intervention":152,"totalTrials":45,"cells":156},{"EARLY_PHASE1":157,"PHASE1":159,"PHASE2":161,"PHASE3":163,"PHASE4":165,"NA":171},{"trials":158,"activeCount":49},[],{"trials":160,"activeCount":49},[],{"trials":162,"activeCount":49},[],{"trials":164,"activeCount":49},[],{"trials":166,"activeCount":49},[167],{"nctId":142,"briefTitle":143,"status":104,"phases":168,"primaryCompletion":145,"completion":146,"start":147,"enrollment":148,"conditions":169,"interventions":170},[41],[150,25],[129,152],{"trials":172,"activeCount":49},[],{"intervention":174,"totalTrials":45,"cells":175},"Intranasal ketamine",{"EARLY_PHASE1":176,"PHASE1":178,"PHASE2":180,"PHASE3":182,"PHASE4":184,"NA":199},{"trials":177,"activeCount":49},[],{"trials":179,"activeCount":49},[],{"trials":181,"activeCount":49},[],{"trials":183,"activeCount":49},[],{"trials":185,"activeCount":49},[186],{"nctId":187,"briefTitle":188,"status":104,"phases":189,"primaryCompletion":190,"completion":191,"start":192,"enrollment":193,"conditions":194,"interventions":195},"NCT02447289","Midazolam and Ketamine Effect Administered Through the Nose for Sedation of Children for Dental Treatment",[41],"2016-10-11","2016-10-18","2015-05-21",84,[23,111],[174,196,197,198],"Oral ketamine","Intranasal midazolam","Oral midazolam",{"trials":200,"activeCount":49},[],{"intervention":196,"totalTrials":45,"cells":202},{"EARLY_PHASE1":203,"PHASE1":205,"PHASE2":207,"PHASE3":209,"PHASE4":211,"NA":217},{"trials":204,"activeCount":49},[],{"trials":206,"activeCount":49},[],{"trials":208,"activeCount":49},[],{"trials":210,"activeCount":49},[],{"trials":212,"activeCount":49},[213],{"nctId":187,"briefTitle":188,"status":104,"phases":214,"primaryCompletion":190,"completion":191,"start":192,"enrollment":193,"conditions":215,"interventions":216},[41],[23,111],[174,196,197,198],{"trials":218,"activeCount":49},[],{"intervention":197,"totalTrials":45,"cells":220},{"EARLY_PHASE1":221,"PHASE1":223,"PHASE2":225,"PHASE3":227,"PHASE4":229,"NA":235},{"trials":222,"activeCount":49},[],{"trials":224,"activeCount":49},[],{"trials":226,"activeCount":49},[],{"trials":228,"activeCount":49},[],{"trials":230,"activeCount":49},[231],{"nctId":187,"briefTitle":188,"status":104,"phases":232,"primaryCompletion":190,"completion":191,"start":192,"enrollment":193,"conditions":233,"interventions":234},[41],[23,111],[174,196,197,198],{"trials":236,"activeCount":49},[],{"intervention":198,"totalTrials":45,"cells":238},{"EARLY_PHASE1":239,"PHASE1":241,"PHASE2":243,"PHASE3":245,"PHASE4":247,"NA":253},{"trials":240,"activeCount":49},[],{"trials":242,"activeCount":49},[],{"trials":244,"activeCount":49},[],{"trials":246,"activeCount":49},[],{"trials":248,"activeCount":49},[249],{"nctId":187,"briefTitle":188,"status":104,"phases":250,"primaryCompletion":190,"completion":191,"start":192,"enrollment":193,"conditions":251,"interventions":252},[41],[23,111],[174,196,197,198],{"trials":254,"activeCount":49},[],{"intervention":256,"totalTrials":45,"cells":257},"Tramadol",{"EARLY_PHASE1":258,"PHASE1":260,"PHASE2":262,"PHASE3":264,"PHASE4":266,"NA":283},{"trials":259,"activeCount":49},[],{"trials":261,"activeCount":49},[],{"trials":263,"activeCount":49},[],{"trials":265,"activeCount":49},[],{"trials":267,"activeCount":49},[268],{"nctId":269,"briefTitle":270,"status":271,"phases":272,"primaryCompletion":273,"completion":274,"start":273,"enrollment":275,"conditions":276,"interventions":280},"NCT03067103","Comparison of Peritonsillar Infiltration of Tramadol Ketamine and Placebo on Pediatric Posttonsillectomy Pain","UNKNOWN",[41],"2017-07-01","2019-05-01",108,[277,278,279],"Sleep Disorder; Breathing-Related","Pain, Postoperative","Child, Only",[256,281,282],"Ketamine","Placebos",{"trials":284,"activeCount":49},[],{"intervention":281,"totalTrials":45,"cells":286},{"EARLY_PHASE1":287,"PHASE1":289,"PHASE2":291,"PHASE3":293,"PHASE4":295,"NA":301},{"trials":288,"activeCount":49},[],{"trials":290,"activeCount":49},[],{"trials":292,"activeCount":49},[],{"trials":294,"activeCount":49},[],{"trials":296,"activeCount":49},[297],{"nctId":269,"briefTitle":270,"status":271,"phases":298,"primaryCompletion":273,"completion":274,"start":273,"enrollment":275,"conditions":299,"interventions":300},[41],[277,278,279],[256,281,282],{"trials":302,"activeCount":49},[],{"intervention":282,"totalTrials":45,"cells":304},{"EARLY_PHASE1":305,"PHASE1":307,"PHASE2":309,"PHASE3":311,"PHASE4":313,"NA":319},{"trials":306,"activeCount":49},[],{"trials":308,"activeCount":49},[],{"trials":310,"activeCount":49},[],{"trials":312,"activeCount":49},[],{"trials":314,"activeCount":49},[315],{"nctId":269,"briefTitle":270,"status":271,"phases":316,"primaryCompletion":273,"completion":274,"start":273,"enrollment":275,"conditions":317,"interventions":318},[41],[277,278,279],[256,281,282],{"trials":320,"activeCount":49},[],{"intervention":322,"totalTrials":45,"cells":323},"Standard vaccination schedule",{"EARLY_PHASE1":324,"PHASE1":326,"PHASE2":328,"PHASE3":330,"PHASE4":332,"NA":347},{"trials":325,"activeCount":49},[],{"trials":327,"activeCount":49},[],{"trials":329,"activeCount":49},[],{"trials":331,"activeCount":49},[],{"trials":333,"activeCount":49},[334],{"nctId":335,"briefTitle":336,"status":271,"phases":337,"primaryCompletion":338,"completion":339,"start":340,"enrollment":341,"conditions":342,"interventions":345},"NCT04540653","Immunogenicity of the Hepatitis B Vaccine",[41],"2020-07-03","2022-03-31","2017-07-29",240,[343,344,19],"Vaccine Response Impaired","Hepatitis B",[322,346],"Reinforced vaccination schedule",{"trials":348,"activeCount":49},[],{"intervention":346,"totalTrials":45,"cells":350},{"EARLY_PHASE1":351,"PHASE1":353,"PHASE2":355,"PHASE3":357,"PHASE4":359,"NA":365},{"trials":352,"activeCount":49},[],{"trials":354,"activeCount":49},[],{"trials":356,"activeCount":49},[],{"trials":358,"activeCount":49},[],{"trials":360,"activeCount":49},[361],{"nctId":335,"briefTitle":336,"status":271,"phases":362,"primaryCompletion":338,"completion":339,"start":340,"enrollment":341,"conditions":363,"interventions":364},[41],[343,344,19],[322,346],{"trials":366,"activeCount":49},[],{"intervention":114,"totalTrials":45,"cells":368},{"EARLY_PHASE1":369,"PHASE1":371,"PHASE2":373,"PHASE3":375,"PHASE4":377,"NA":383},{"trials":370,"activeCount":49},[],{"trials":372,"activeCount":49},[],{"trials":374,"activeCount":49},[],{"trials":376,"activeCount":49},[],{"trials":378,"activeCount":49},[379],{"nctId":102,"briefTitle":103,"status":104,"phases":380,"primaryCompletion":106,"completion":107,"start":108,"enrollment":109,"conditions":381,"interventions":382},[41],[111,23,112],[89,114],{"trials":384,"activeCount":49},[],{"intervention":386,"totalTrials":45,"cells":387},"Lidocaine",{"EARLY_PHASE1":388,"PHASE1":390,"PHASE2":392,"PHASE3":394,"PHASE4":409,"NA":411},{"trials":389,"activeCount":49},[],{"trials":391,"activeCount":49},[],{"trials":393,"activeCount":49},[],{"trials":395,"activeCount":49},[396],{"nctId":397,"briefTitle":398,"status":271,"phases":399,"primaryCompletion":400,"completion":401,"start":402,"enrollment":403,"conditions":404,"interventions":407},"NCT02801786","TAmoxifen Versus LIdocaine Cream. A Randomized Clinical Trial for Reducing Pain and Discomfort During Mammography",[39,40],"2020-11","2021-06","2018-11",450,[405,406],"Pain","Discomfort",[386,408],"Tamoxifen",{"trials":410,"activeCount":49},[],{"trials":412,"activeCount":49},[],{"intervention":408,"totalTrials":45,"cells":414},{"EARLY_PHASE1":415,"PHASE1":417,"PHASE2":419,"PHASE3":421,"PHASE4":427,"NA":429},{"trials":416,"activeCount":49},[],{"trials":418,"activeCount":49},[],{"trials":420,"activeCount":49},[],{"trials":422,"activeCount":49},[423],{"nctId":397,"briefTitle":398,"status":271,"phases":424,"primaryCompletion":400,"completion":401,"start":402,"enrollment":403,"conditions":425,"interventions":426},[39,40],[405,406],[386,408],{"trials":428,"activeCount":49},[],{"trials":430,"activeCount":49},[],{"intervention":432,"totalTrials":45,"cells":433},"Bevacizumab",{"EARLY_PHASE1":434,"PHASE1":436,"PHASE2":438,"PHASE3":452,"PHASE4":454,"NA":456},{"trials":435,"activeCount":49},[],{"trials":437,"activeCount":49},[],{"trials":439,"activeCount":49},[440],{"nctId":441,"briefTitle":442,"status":104,"phases":443,"primaryCompletion":444,"completion":445,"start":446,"enrollment":447,"conditions":448,"interventions":450},"NCT00874744","Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema",[39],"2008-09","2008-10","2008-03",13,[449],"Diabetic Macular Edema",[432,451],"Triamcinolone acetonide",{"trials":453,"activeCount":49},[],{"trials":455,"activeCount":49},[],{"trials":457,"activeCount":49},[],{"intervention":451,"totalTrials":45,"cells":459},{"EARLY_PHASE1":460,"PHASE1":462,"PHASE2":464,"PHASE3":470,"PHASE4":472,"NA":474},{"trials":461,"activeCount":49},[],{"trials":463,"activeCount":49},[],{"trials":465,"activeCount":49},[466],{"nctId":441,"briefTitle":442,"status":104,"phases":467,"primaryCompletion":444,"completion":445,"start":446,"enrollment":447,"conditions":468,"interventions":469},[39],[449],[432,451],{"trials":471,"activeCount":49},[],{"trials":473,"activeCount":49},[],{"trials":475,"activeCount":49},[],{"intervention":477,"totalTrials":45,"cells":478},"Midazolam, Ketamine and Sevoflurane",{"EARLY_PHASE1":479,"PHASE1":481,"PHASE2":483,"PHASE3":496,"PHASE4":498,"NA":500},{"trials":480,"activeCount":49},[],{"trials":482,"activeCount":49},[],{"trials":484,"activeCount":49},[485],{"nctId":486,"briefTitle":487,"status":104,"phases":488,"primaryCompletion":489,"completion":490,"start":491,"enrollment":492,"conditions":493,"interventions":494},"NCT02284204","Sevoflurane Associated With Oral Midazolam and Ketamine for Dental Sedation",[39],"2014-08","2014-11","2012-01",27,[25],[477,495],"Midazolam and Ketamine",{"trials":497,"activeCount":49},[],{"trials":499,"activeCount":49},[],{"trials":501,"activeCount":49},[],{"intervention":495,"totalTrials":45,"cells":503},{"EARLY_PHASE1":504,"PHASE1":506,"PHASE2":508,"PHASE3":514,"PHASE4":516,"NA":518},{"trials":505,"activeCount":49},[],{"trials":507,"activeCount":49},[],{"trials":509,"activeCount":49},[510],{"nctId":486,"briefTitle":487,"status":104,"phases":511,"primaryCompletion":489,"completion":490,"start":491,"enrollment":492,"conditions":512,"interventions":513},[39],[25],[477,495],{"trials":515,"activeCount":49},[],{"trials":517,"activeCount":49},[],{"trials":519,"activeCount":49},[],{"intervention":521,"totalTrials":45,"cells":522},"Oral isotretinoin",{"EARLY_PHASE1":523,"PHASE1":525,"PHASE2":527,"PHASE3":542,"PHASE4":544,"NA":546},{"trials":524,"activeCount":49},[],{"trials":526,"activeCount":49},[],{"trials":528,"activeCount":49},[529],{"nctId":530,"briefTitle":531,"status":104,"phases":532,"primaryCompletion":533,"completion":534,"start":535,"enrollment":536,"conditions":537,"interventions":539},"NCT02278861","Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis",[39],"2014-04","2014-05","2011-11",60,[538],"Actinic Keratosis",[521,540,541],"Tretinoin 0,05% cream","Sunscreen FPS 60",{"trials":543,"activeCount":49},[],{"trials":545,"activeCount":49},[],{"trials":547,"activeCount":49},[],{"intervention":540,"totalTrials":45,"cells":549},{"EARLY_PHASE1":550,"PHASE1":552,"PHASE2":554,"PHASE3":560,"PHASE4":562,"NA":564},{"trials":551,"activeCount":49},[],{"trials":553,"activeCount":49},[],{"trials":555,"activeCount":49},[556],{"nctId":530,"briefTitle":531,"status":104,"phases":557,"primaryCompletion":533,"completion":534,"start":535,"enrollment":536,"conditions":558,"interventions":559},[39],[538],[521,540,541],{"trials":561,"activeCount":49},[],{"trials":563,"activeCount":49},[],{"trials":565,"activeCount":49},[],{"intervention":541,"totalTrials":45,"cells":567},{"EARLY_PHASE1":568,"PHASE1":570,"PHASE2":572,"PHASE3":578,"PHASE4":580,"NA":582},{"trials":569,"activeCount":49},[],{"trials":571,"activeCount":49},[],{"trials":573,"activeCount":49},[574],{"nctId":530,"briefTitle":531,"status":104,"phases":575,"primaryCompletion":533,"completion":534,"start":535,"enrollment":536,"conditions":576,"interventions":577},[39],[538],[521,540,541],{"trials":579,"activeCount":49},[],{"trials":581,"activeCount":49},[],{"trials":583,"activeCount":49},[],{"intervention":585,"totalTrials":45,"cells":586},"Zolpidem",{"EARLY_PHASE1":587,"PHASE1":600,"PHASE2":602,"PHASE3":604,"PHASE4":606,"NA":608},{"trials":588,"activeCount":49},[589],{"nctId":590,"briefTitle":591,"status":104,"phases":592,"primaryCompletion":593,"completion":594,"start":595,"enrollment":596,"conditions":597,"interventions":599},"NCT03160404","Zolpidem or Exercise for Insomnia?",[37],"2019-12-30","2020-02-15","2018-04-16",34,[598],"Chronic Insomnia",[585],{"trials":601,"activeCount":49},[],{"trials":603,"activeCount":49},[],{"trials":605,"activeCount":49},[],{"trials":607,"activeCount":49},[],{"trials":609,"activeCount":49},[],{"intervention":611,"totalTrials":45,"cells":612},"ferrous sulfate",{"EARLY_PHASE1":613,"PHASE1":615,"PHASE2":617,"PHASE3":619,"PHASE4":621,"NA":623},{"trials":614,"activeCount":49},[],{"trials":616,"activeCount":49},[],{"trials":618,"activeCount":49},[],{"trials":620,"activeCount":49},[],{"trials":622,"activeCount":49},[],{"trials":624,"activeCount":49},[625],{"nctId":626,"briefTitle":627,"status":104,"phases":628,"primaryCompletion":629,"completion":629,"start":630,"enrollment":631,"conditions":632,"interventions":634},"NCT00701246","Treatment and Prevention of Anemia With Ferrous Sulfate Plus Folic Acid in Children in Goiania - Goias, Brazil",[42],"2006-03","2005-04",196,[633],"Anemia",[611,635],"folic acid",{"intervention":635,"totalTrials":45,"cells":637},{"EARLY_PHASE1":638,"PHASE1":640,"PHASE2":642,"PHASE3":644,"PHASE4":646,"NA":648},{"trials":639,"activeCount":49},[],{"trials":641,"activeCount":49},[],{"trials":643,"activeCount":49},[],{"trials":645,"activeCount":49},[],{"trials":647,"activeCount":49},[],{"trials":649,"activeCount":49},[650],{"nctId":626,"briefTitle":627,"status":104,"phases":651,"primaryCompletion":629,"completion":629,"start":630,"enrollment":631,"conditions":652,"interventions":653},[42],[633],[611,635]]